Arax Advisory Partners’s LeMaitre Vascular LMAT Stock Holding History

Arax Advisory Partners’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$62.1K	Buy	569 +1	+0.2%	+$95	﹤0.01%	1591
2025 Q4	$46K	Sell	568 -280	-33%	-$24.1K	﹤0.01%	1648
2025 Q3	$74.2K	Sell	848 -495	-37%	-$44.2K	﹤0.01%	1659
2025 Q2	$112K	Buy	1,343 +790	+143%	+$66K	0.01%	885
2025 Q1	$46.4K	Sell	553 -7	-1%	-$651	﹤0.01%	972
2024 Q4	$51.6K	Hold	560	–	–	﹤0.01%	890
2024 Q3	$52K	Sell	560 -74	-12%	-$6.41K	﹤0.01%	706
2024 Q2	$52.2K	Sell	634 -50	-7%	-$3.67K	0.01%	643
2024 Q1	$45.4K	Sell	684 -1	-0.1%	-$62	﹤0.01%	521
2023 Q4	$38.9K	Buy	685 +524	+325%	+$27.4K	﹤0.01%	528
2023 Q3	$8.75K	Buy	161 +1	+0.6%	+$59	﹤0.01%	751
2023 Q2	$10.8K	Hold	160	–	–	﹤0.01%	691
2023 Q1	$8.25K	Sell	160 -1	-0.6%	-$49	﹤0.01%	726
2022 Q4	$7.41K	Hold	161	–	–	﹤0.01%	696
2022 Q3	$8K	Hold	161	–	–	﹤0.01%	692
2022 Q2	$7K	Buy	161 +1	+0.6%	+$45	﹤0.01%	704
2022 Q1	$7K	Buy	160 +40	+33%	+$1.79K	﹤0.01%	706
2021 Q4	$6K	Sell	120 -42	-26%	-$2.17K	﹤0.01%	740
2021 Q3	$9K	Hold	162	–	–	﹤0.01%	661
2021 Q2	$10K	Buy	+162	New	+$8.61K	﹤0.01%	666

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Arax Advisory Partners's LMAT Position: Q1 2026 in Review

Arax Advisory Partners increased its LeMaitre Vascular (LMAT) stake by 0.18% in Q1 2026, buying an estimated $95 and bringing the position to 569 shares worth $62.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1591.

Arax Advisory Partners first reported a position in LMAT in Q2 2021 and has held it in 20 quarters since. The position peaked at $112K in Q2 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

Arax Advisory Partners held 569 shares of LeMaitre Vascular worth $62.1K as of Q1 2026.
Arax Advisory Partners bought 1 LeMaitre Vascular share in Q1 2026, an estimated $95.
LeMaitre Vascular made up ﹤0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #1591 holding.
Arax Advisory Partners first reported a position in LeMaitre Vascular in Q2 2021 and has held it in 20 quarters since.
Arax Advisory Partners's LeMaitre Vascular position peaked at $112K in Q2 2025.
339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.